Accelerating Clinical Entry Through Regulatory Innovation

Join us in London for an expert-led seminar designed to help emerging pharma and biotech companies fast-track their clinical programs. With sweeping reforms to UK clinical trial regulations now in motion, and adaptive trial models gaining traction, success depends on smart development strategies, right-first-time formulation, and a supply chain built for agility.

As UK clinical trial regulations evolve and adaptive trial designs gain momentum, emerging biopharma companies must act fast and plan smart. This focused seminar brings together regulatory, formulation, and clinical supply experts to help streamline development, reduce risk, and enable faster clinical entry.

Explore the key phases of small molecule development. Learn how to effectively integrate formulation design with clinical planning, align development timelines with trial logistics, and utilize recent regulatory changes to gain a competitive edge. You'll gain valuable insights, tools, and connections to mitigate risks in development, optimize your strategy, and accelerate your innovation toward market success. Additionally, take advantage of exclusive one-on-one office hours with our experts to discuss the challenges you face with your molecule.

Key Learning Objectives

1. Gain clarity on the 2024 amendments to the Medicines for Human Use (Clinical Trials) Regulations and their implications for trial sponsors.

2. Discover how Catalent’s Xpress Pharmaceutics™ and integrated development platform enable faster clinical entry through formulation technologies that support dose flexibility and seamless scale-up.

3. Discover best practices in clinical logistics planning and global distribution to support clinical trials, minimizing risk and accelerating patient access.

Who Should Attend

Professionals in Preclinical & Formulation Development, CMC, Drug Substance & Product Development, Project Management, Manufacturing & Operations, Supply Chain Management, and pharma consultants seeking a CDMO partner for developing and manufacturing oral solid dosage forms.